192 related articles for article (PubMed ID: 16421247)
1. CD99 acts as an oncosuppressor in osteosarcoma.
Manara MC; Bernard G; Lollini PL; Nanni P; Zuntini M; Landuzzi L; Benini S; Lattanzi G; Sciandra M; Serra M; Colombo MP; Bernard A; Picci P; Scotlandi K
Mol Biol Cell; 2006 Apr; 17(4):1910-21. PubMed ID: 16421247
[TBL] [Abstract][Full Text] [Related]
2. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
Zucchini C; Manara MC; Pinca RS; De Sanctis P; Guerzoni C; Sciandra M; Lollini PL; Cenacchi G; Picci P; Valvassori L; Scotlandi K
Oncogene; 2014 Apr; 33(15):1912-21. PubMed ID: 23644663
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
[TBL] [Abstract][Full Text] [Related]
4. CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.
Sciandra M; Marino MT; Manara MC; Guerzoni C; Grano M; Oranger A; Lucarelli E; Lollini PL; Dozza B; Pratelli L; Renzo MF; Colombo MP; Picci P; Scotlandi K
J Bone Miner Res; 2014; 29(5):1295-309. PubMed ID: 24677094
[TBL] [Abstract][Full Text] [Related]
5. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
Oncogene; 2007 Oct; 26(46):6604-18. PubMed ID: 17471235
[TBL] [Abstract][Full Text] [Related]
6. Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model.
Grilli A; Sciandra M; Terracciano M; Picci P; Scotlandi K
BMC Med Genomics; 2015 Jun; 8():34. PubMed ID: 26123714
[TBL] [Abstract][Full Text] [Related]
7. CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.
Úrias U; Marie SK; Uno M; da Silva R; Evagelinellis MM; Caballero OL; Stevenson BJ; Silva WA; Simpson AJ; Oba-Shinjo SM
J Neurooncol; 2014 Aug; 119(1):59-70. PubMed ID: 24797829
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of CD99 down-regulation in gastric adenocarcinoma.
Lee JH; Kim SH; Wang LH; Choi YL; Kim YC; Kim JH; Park TS; Hong YC; Shin YK
Clin Cancer Res; 2007 May; 13(9):2584-91. PubMed ID: 17473187
[TBL] [Abstract][Full Text] [Related]
9. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
10. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
[TBL] [Abstract][Full Text] [Related]
11. Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.
Oranger A; Brunetti G; Carbone C; Colaianni G; Mongelli T; Gigante I; Tamma R; Mori G; Di Benedetto A; Sciandra M; Ventura S; Scotlandi K; Colucci S; Grano M
J Immunol Res; 2015; 2015():156787. PubMed ID: 26000312
[TBL] [Abstract][Full Text] [Related]
12. HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
[TBL] [Abstract][Full Text] [Related]
13. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2).
Kim SH; Choi EY; Shin YK; Kim TJ; Chung DH; Chang SI; Kim NK; Park SH
Blood; 1998 Dec; 92(11):4287-95. PubMed ID: 9834235
[TBL] [Abstract][Full Text] [Related]
14. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
15. SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.
Jian W; Zhong L; Wen J; Tang Y; Qiu B; Wu Z; Yan J; Zhou X; Zhao T
PLoS One; 2015; 10(5):e0127568. PubMed ID: 26000982
[TBL] [Abstract][Full Text] [Related]
16. Identification of CBFA1-regulated genes on SaOs-2 cells.
Bertaux K; Broux O; Chauveau C; Jeanfils J; Devedjian JC
J Bone Miner Metab; 2005; 23(2):114-22. PubMed ID: 15750689
[TBL] [Abstract][Full Text] [Related]
17. Deregulated WWOX is involved in a negative feedback loop with microRNA-214-3p in osteosarcoma.
Gao K; Yin J; Dong J
Int J Mol Med; 2016 Dec; 38(6):1850-1856. PubMed ID: 27840941
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
Duan N; Hu X; Yang X; Cheng H; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733
[TBL] [Abstract][Full Text] [Related]
19. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
